Left Atrial Appendage Closure Device Thrombosis Despite Therapeutic Anticoagulation with Rivaroxaban

Cardiovasc Revasc Med. 2023 Aug:53:76-79. doi: 10.1016/j.carrev.2023.04.018. Epub 2023 Apr 26.

Authors

Samantha Walkin¹, Kashvi Patel¹, Abdelmoniem Moustafa², Robert Grande³

Affiliations

¹ College of Medicine and Life Sciences at University of Toledo, Toledo, OH, USA.
² Division of Cardiovascular Medicine, University of Toledo, Toledo, OH, USA. Electronic address: Abdelmoniem.moustafa@utoledo.edu.
³ Division of Cardiovascular Medicine, Toledo Hospital, Promedica, Toledo, OH, USA.

PMID: 37127481
DOI: 10.1016/j.carrev.2023.04.018

No abstract available

Keywords: DOAC; DRT; LAAC; Watchman device.

MeSH terms

Anticoagulants / adverse effects
Atrial Appendage* / diagnostic imaging
Atrial Appendage* / surgery
Atrial Fibrillation* / diagnosis
Atrial Fibrillation* / drug therapy
Humans
Rivaroxaban / adverse effects
Stroke* / diagnosis
Stroke* / etiology
Stroke* / prevention & control
Thrombosis* / diagnostic imaging
Thrombosis* / etiology
Thrombosis* / prevention & control
Treatment Outcome
Warfarin

Substances

Rivaroxaban
Warfarin
Anticoagulants